Loading presentation...

Present Remotely

Send the link below via email or IM


Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.


European drug prevention quality standards

For more information please visit www.prevention-standards.eu

Angelina Brotherhood

on 24 October 2013

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of European drug prevention quality standards

The European Drug Prevention Quality Standards
Background to Phase 1
Follow-on project - Phase 2
The Prevention Standards Partnership (Phase 1)
Cross-cutting considerations
1 Needs assessment
2 Resource assessment
3 Programme formulation
4 Intervention design
5 Management and mobilisation of resources
6 Delivery and monitoring
7 Final evaluations
8 Dissemination and improvement
A: Sustainability and funding
B: Communication and stakeholder involvement
C: Staff development
D: Ethical drug prevention
The drug prevention project cycle
Introduction to the Standards
At the time of starting Phase 1:
No EU-level guidance on evidence-based drug prevention
National or regional guidance available in some countries – applicable to wider EU?
USA standards of evidence – applicable to European context?
Lack of guidance for policy makers and practitioners

Aims of Phase 1:
To bridge the gaps between science, policy and practice
To produce a set of evidence-based drug prevention standards for use in the EU
To provide a checklist for policy makers and practitioners
Liverpool John Moores University (LJMU), United Kingdom (Project lead)
Azienda Sanitaria Locale della Città di Milano (ASL), Italy
Consejeria de Sanidad - Servicio Gallego de Salud (Xunta de Galicia) (CS-SERGAS), Spain
Azienda Sanitaria Locale n. 2 - Savonese (ASL2), Italy
Institute for Social Policy and Labour (SZMI-NDI), Hungary
National Anti-Drug Agency (NAA), Romania
National Bureau for Drug Prevention (NBDP), Poland
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
- a model to be adopted and adapted
1.1 Knowing drug-related policy and legislation
1.2 Assessing drug use and community needs
1.3 Describing the need – Justifying the intervention
1.4 Understanding the target population
2.1 Assessing target population and community resources
2.2 Assessing internal capacities
3.1 Defining the target population
3.2 Using a theoretical model
3.3 Defining aims, goals, and objectives
3.4 Defining the setting
3.5 Referring to evidence of effectiveness
3.6 Determining the timeline
4.1 Designing for quality and effectiveness
4.2 If selecting an existing intervention
4.3 Tailoring the intervention to the target population
4.4 If planning final evaluation
5.1 Planning the programme — Illustrating the project plan
5.2 Planning financial requirements
5.3 Setting up the team
5.4 Recruiting and retaining participants
5.5 Preparing programme materials
5.6 Providing a programme description
6.1 If conducting a pilot intervention
6.2 Implementing the intervention
6.3 Monitoring the implementation
6.4 Adjusting the implementation
7.1 If conducting an outcome evaluation
7.2 If conducting a process evaluation
8.1 Determining whether the programme should be sustained
8.2 Disseminating information about the programme
8.3 If producing a final report
About the project
Using the standards
Development of the Standards
More focus groups - developing a practical checklist

Final version
EMCDDA publication
(December 2011)
In spring 2009, drug prevention standards and/or guidelines were available from 12 EU countries:

Czech Republic
Italy (regionally)
Spain (Galicia)
United Kingdom

9 EU countries: no standards (yet)
6 EU countries: no information received
Consultations took place in six countries
with over 400 professionals
Galicia (Spain)
United Kingdom

Sampling frame covered ten professional backgrounds:
Regional drug teams or networks
Mental Health
Social services/ Children, young people, families
Criminal Justice
Voluntary/ Community sector
Government representatives
Prevention consultants
Project Funders for Phase 1
The EMCDDA Manual
Available for download and to order for free from:
Supporting materials including self-reflection checklist
Name of the standard
Implementation considerations
Detailed standards (basic level)
Detailed standards (expert level)
Examples to clarify
What's next?
Publication of the standards as a manual is
sufficient to ensure their implementation in the field


Lack of knowledge on how to use standards, and what for
Diversity of prevention work
Scepticism among professional groups
Examples of how the Manual could be used
Drug prevention activities that are:
relevant, ethical, evidence-based, (cost)effective, feasible and sustainable

Extended Prevention Standards Partnership with 15 organisations
April 2013 - March 2015
Co-funded by the European Union through the European Commission's DG-Justice "Drug Prevention and Information Programme" (DPIP)

Trial usefulness and applicability of standards under ‘real’ circumstances in different countries and settings
Produce user-friendly implementation toolkits for different audiences and purposes

For further information, please visit
Delphi survey - perceived priority
Focus groups - cultural relevance

Second draft
Collecting available guidance
77 documents identified
19 documents selected
Synthesising available guidance

First draft

Guidance in planning new activities:
A commissioner refers to the standards to conduct a local needs assessment using Project stage 1 (Needs assessment).

Preparing funding applications:
A prevention provider is preparing a project proposal to a funding body. The lead applicant uses the self-reflection checklist accompanying the standards to ensure that all project stages have been considered sufficiently.

Discussing ongoing activities in a group setting:
The senior management team of a large prevention provider uses the standards in a monthly meeting to discuss strengths and weaknesses of the organisation.

Professional development:
A practitioner working for a charity reads the standards for general information. Standard 3.2 (Using a theoretical model) encourages him to find out more about prevention theories and to identify theoretical models that might lead to improvements in his own working approach.

Visit www.prevention-standards.eu
for real-life examples of use
For further information please contact:

Jeff Lee, Project Manager
Centre for Public Health
Liverpool John Moores University, UK

Presentation prepared by:
Angelina Brotherhood
Public Health Researcher
Full transcript